Risk Factors for Progressive Supranuclear Palsy (PSP)
Public ClinicalTrials.gov record NCT00431301. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Genetic and Environmental Risk Factors for PSP
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Progressive supranuclear palsy (PSP) is the most common atypical parkinsonian movement disorder. This study will determine the role of specific genetic, occupational and environmental components in the development of PSP by evaluating patients with this disorder and age and gender matched controls.
Study identification
- NCT ID
- NCT00431301
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 942 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2006
- Primary completion
- Jan 31, 2013
- Completion
- May 31, 2013
- Last update posted
- Apr 9, 2017
2006 – 2013
United States locations
- U.S. sites
- 9
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama, Birmingham | Birmingham | Alabama | 35233 | — |
| UCLA | Los Angeles | California | 90095-1759 | — |
| University of Colorado | Aurora | Colorado | 80045 | — |
| Emory College of Medicine | Atlanta | Georgia | 30322 | — |
| Rush University | Chicago | Illinois | 60611 | — |
| University of Kansas | Kansas City | Kansas | 66160 | — |
| University of Louisville | Louisville | Kentucky | 40202 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| Case Western University | Cleveland | Ohio | 44106 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
Recently updated Progressive Supranuclear Palsy trials
Other public records listing Progressive Supranuclear Palsy. Sorted by last update posted; newest first. Not a recommendation.
- NCT02605785: A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy Recruiting
- NCT03225144: Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Recruiting
- NCT05222386: Community Outreach for Palliative Engagement -- Parkinson Disease Active, not recruiting
- NCT03872102: Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging Recruiting
- NCT06588673: Art Therapy in Progressive Supranuclear Palsy Active, not recruiting
- NCT05956834: A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00431301, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 9, 2017 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00431301 live on ClinicalTrials.gov.